Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
GLP-1 medications compress decades of natural volume loss into months
Losing muscle can reduce metabolic rate, making it harder to sustain weight loss and leading to a host of other health issues, such as decreased strength and mobility
CJC-1295 no DAC: 0.1mg Ipamorelin: 0.15mg BPC-157: 0.25mg GHK-Cu: 1mg CJC-1295 no DAC: 0.1mg Ipamorelin: 0.15mg BPC-157: 0.25mg (optional second dose) TB-500: 2.5mg during loading, 2mg maintenance Tirzepatide: Per prescribed escalation schedule This protocol requires significant commitment to injection frequency but addresses all major concerns simultaneously
Tirzepatide data comes from the SURMOUNT-1 trial, NCT04184622, using the 15 milligram maintenance dose arm
ACS Chem Neurosci 16:818825 Dickson SL, Shirazi RH, Hansson C et al (2012) The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors
You can see this commitment across our entire collection of peptides, each one synthesized to empower discovery
US$ 22.68
US$ 22.00
US$ 22.83
US$ 25.98
US$ 27.92
US$ 20.84
US$ 20.14
US$ 23.95
